These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6441780)

  • 1. Simple method for preparation of cryoprecipitate (CP) and cryodepleted plasma (CDP).
    Prohaska W; Kretschmer V
    Infusionsther Klin Ernahr; 1984 Dec; 11(6):342-4. PubMed ID: 6441780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protocol for the preparation of cryoprecipitate and cryodepleted plasma.
    Sparrow RL; Greening DW; Simpson RJ
    Methods Mol Biol; 2011; 728():259-65. PubMed ID: 21468954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III.
    Chirnside A; Urbaniak SJ; Prowse CV; Keller AJ
    Br J Haematol; 1981 Aug; 48(4):627-34. PubMed ID: 6791676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
    Stokol T; Parry B
    J Vet Intern Med; 1998; 12(2):84-92. PubMed ID: 9560764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days.
    Smak Gregoor PJ; Harvey MS; Briët E; Brand A
    Transfusion; 1993 Sep; 33(9):735-8. PubMed ID: 8212120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave-thawed plasma for cryoprecipitate production.
    Bass H; Trenchard PM; Mustow MJ
    Vox Sang; 1985; 48(2):65-71. PubMed ID: 3934842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the products of cryoprecipitation: RiCoF is deficient in cryosupernatant plasma.
    Freedman M; Rock G
    Transfus Apher Sci; 2010 Oct; 43(2):179-82. PubMed ID: 20719565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III in fresh frozen plasma, cryoprecipitate, and cryoprecipitate-depleted plasma.
    Mintz PD; Blatt PM; Kuhns WJ; Roberts HR
    Transfusion; 1979; 19(5):597-8. PubMed ID: 505534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma.
    Culler CA; Iazbik C; Guillaumin J
    J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):638-644. PubMed ID: 29064153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of a therapeutic concentrate of factor VIII/vWf prepared in a closed system].
    Mazurier C; Maillard J; Parquet-Gernez A; Goudemand M
    Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):25-43. PubMed ID: 6803339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII (AHF) activity of small size produced by succinylating plasma.
    Barrow EM; Graham JB
    Am J Physiol; 1972 Jan; 222(1):134-41. PubMed ID: 4536749
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Test for detection of hemophilia].
    Poppa C; Enache F; Cernat M
    Stud Cercet Med Interna; 1970; 11(6):521-31. PubMed ID: 5313814
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor and hemostatic protein content of canine plasma after storage of whole blood at ambient temperature.
    Walton JE; Hale AS; Brooks MB; Boag AK; Barnett W; Dean R
    J Vet Intern Med; 2014; 28(2):571-5. PubMed ID: 24467263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of methods of freezing and thawing of blood plasma on the activity of procoagulants and antithrombin-III].
    Baryshev BA; Selivanov EA; Kobilianskaia VI; Andozhskaia IV; Kurenkova VV; Papaian LP
    Vestn Khir Im I I Grek; 2000; 159(6):55-6. PubMed ID: 11209233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A.
    Stokol T; Trepanier L; Parry BW; Finnin BC
    Res Vet Sci; 1997; 63(1):23-7. PubMed ID: 9368952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.